Xiang-ru Zhang

发表

[Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].

Wei Zhang, Yan Wang, Jun Fu, 2004, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].

W. Tan, X. Miao, Bing-he Xu, 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer].

W. Tan, X. Miao, Bing-he Xu, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma

Yuankai Shi, Jian-ping Xu, Xiaoyan Liu, 2016, OncoTargets and therapy.

吉非替尼治疗32例肺腺癌脑转移的临床经验

Yuankai Shi, Jian-ping Xu, Xiaoyan Liu, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Efficacy of pemetrexed as second-line therapy or beyond in patients with advanced non-small cell lung cancer].

Junling Li, Yuankai Shi, X. Hao, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

Yuankai Shi, Jian-ping Xu, Xiaoyan Liu, 2017, OncoTargets and therapy.

吉非替尼治疗晚期非小细胞肺癌耐药后的进展模式分析

Junling Li, Yuankai Shi, X. Hao, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Efficacy of icotinib in lung squamous‐cell cancer: A real‐world experience from single institution

Yuankai Shi, Jian-ping Xu, Xiaoyan Liu, 2017, Asia-Pacific journal of clinical oncology.

伊立替康联合奈达铂对比联合顺铂二线治疗复发或难治性小细胞肺癌的疗效及毒副作用回顾分析

Junling Li, Yuankai Shi, Yan Wang, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study

Junling Li, Yuankai Shi, Yan Wang, 2013, Thoracic cancer.

[Local treatment combined with EGFR-TKIs for advanced non-small cell lung cancer with solitary progression during EGFR-TKI treatment].

Junling Li, Yuankai Shi, X. Hao, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

初始易瑞沙治疗有效的晚期肺腺癌二次使用易瑞沙的疗效分析

Junling Li, Yuankai Shi, Yan Wang, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and two case reports

P. Xing, Junling Li, Yuankai Shi, 2014, Thoracic cancer.

Phase II trial of paclitaxel‐carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non‐small cell lung cancer

Junling Li, Yuankai Shi, X. Hao, 2014, Thoracic cancer.

191例EGFR突变状态不明晚期肺腺癌患者EGFR-TKIs耐药后化疗的疗效分析

P. He, Junling Li, Yuankai Shi, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

EGFR-TKIs治疗晚期非小细胞肺癌获益后出现缓慢进展的治疗选择：附32例病例总结

P. Xing, Junling Li, Yuankai Shi, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].

W. Tan, X. Miao, Bing-he Xu, 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

吉西他滨顺铂联合索拉非尼或安慰剂一线治疗晚期非小细胞肺癌的随机对照研究

Yuankai Shi, Shufei Yu, Yan Sun, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Clinical response to apatinib monotherapy in advanced non‐small cell lung cancer

Yuankai Shi, Xiaoyan Liu, Sheng Yang, 2018, Asia-Pacific journal of clinical oncology.

[A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients].

X. Hao, Jifeng Feng, Yan Sun, 2006, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer

Junling Li, Luhua Wang, W. Ji, 2011, Radiation oncology.

Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer.

Shixiu Wu, Jun Liang, Junling Li, 2012, Lung cancer.

Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma

Yuankai Shi, X. Hao, Xiang-ru Zhang, 2015, Thoracic cancer.

Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer.

P. Xing, Yuankai Shi, Jun-ling Li, 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[Primary result of the efficacy and tolerance of gefitinib in advanced non-small cell lung cancer patients with brain metastasis].

D. Chu, Yan Wang, Bin Wang, 2006, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Our experience of surgical treatment of small-cell lung cancer: P1-237

Yu-Mei Shi, K. Sun, Yan Sun, 2007 .

吉非替尼治疗EGFR基因突变状态不明的青年晚期肺腺癌疗效分析

Junling Li, X. Hao, Ziping Wang, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Oncotargets and Therapy Dovepress Dovepress Efficacy and Safety of Icotinib in Patients with Brain Metastases from Lung Adenocarcinoma

Yuankai Shi, Xiaoyan Liu, Xiang-ru Zhang, 2022 .

[Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy].

X. Miao, Bing-he Xu, P. Yuan, 2005, Ai zheng = Aizheng = Chinese journal of cancer.

Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study

Junling Li, Yuankai Shi, Yan Wang, 2013, Thoracic cancer.